MedPath

酒泉大得利制药股份有限公司

Ownership
-
Established
2003-04-21
Employees
-
Market Cap
-
Website
http://dadeli.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

144

NMPA:144

Drug Approvals

Glycine

Product Name
甘氨酸
Approval Number
国药准字H62020925
Approval Date
Jun 21, 2024
NMPA

Cytidine Disodium Triphosphate

Product Name
三磷酸胞苷二钠
Approval Number
国药准字H20059755
Approval Date
Jun 21, 2024
NMPA

Thiotepa

Product Name
塞替派
Approval Number
国药准字H62020903
Approval Date
Jun 21, 2024
NMPA

Cystine

Product Name
l-胱氨酸
Approval Number
国药准字H62021267
Approval Date
Jun 21, 2024
NMPA

Salsalate

Product Name
双水杨酯
Approval Number
国药准字H62020904
Approval Date
Jun 21, 2024
NMPA

Primidone

Product Name
扑米酮
Approval Number
国药准字H62020899
Approval Date
Jun 21, 2024
NMPA

SULFANILAMIDUM CRYSTALLINUM STERILE

Product Name
灭菌结晶磺胺
Approval Number
国药准字H62020898
Approval Date
Jun 21, 2024
NMPA

Thymopentin

Product Name
胸腺五肽
Approval Number
国药准字H20084011
Approval Date
Jun 21, 2024
NMPA

Marine

Product Name
苦参素
Approval Number
国药准字H62020893
Approval Date
May 21, 2024
NMPA

Vitamin A Palmitate

Product Name
维生素A棕榈酸酯
Approval Number
国药准字H20083719
Approval Date
May 21, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.